SCHEMBL4478239

SCHEMBL4478239

Clc1cc(Cl)cc(C(Cl)(Cl)c2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.53
CYP3A4 P08684 3/20 0.40
TP53 P04637 1/20 0.40
ALDH1A1 P00352 2/20 0.35
AHR P35869 2/20 0.33
TPMT P51580 1/20 0.33
MAPK1 P28482 2/20 0.32
HIF1A Q16665 1/20 0.32
RECQL P46063 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
IDO1 P14902 1/20 0.31
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7096749 0.80 TSHR (0.53) TSHRCYP3A4TP53ALDH1A1AHR
SCHEMBL9403849 0.75 TSHR (0.47) TSHRCYP3A4TP53ALDH1A1AHR
SCHEMBL7930028 0.73 TSHR (0.44) TSHRCYP3A4TP53ALDH1A1MAPK1
1,3,5-Trichlorobenzene SCHEMBL429512 0.73
1,3,5-Trichlorobenzene SCHEMBL23244766 0.72 TSHR (0.61) TSHRCYP3A4TP53ALDH1A1AHR
SCHEMBL4463685 0.71 CYP19A1 (0.46) TSHRCYP3A4ALDH1A1MAPK1TDP1
SCHEMBL321756 0.71 AHR (0.52) TSHRCYP3A4TP53ALDH1A1AHR
SCHEMBL803437 0.71 TSHR (0.50) TSHRCYP3A4TP53ALDH1A1HSD17B10
SCHEMBL673309 0.71 TSHR (0.50) TSHRCYP3A4TP53ALDH1A1AHR
SCHEMBL11611118 0.69 TSHR (0.39) TSHRCYP3A4TP53ALDH1A1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 TSHR 1029/4885CYP3A4 313/4885TP53 4831/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 TSHR 1171/4885CYP3A4 273/4885TP53 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.